Literature DB >> 33476538

[Clinicopathological features of children with lupus nephritis with positive antineutrophil cytoplasmic antibody].

Si-Jia Wen1, Li-Zhi Chen1, Cheng Cheng1, Zhi-Lang Lin1, Ying Mo1, Xiao-Yun Jiang1.   

Abstract

OBJECTIVE: To study the clinicopathological features of children with lupus nephritis (LN) with positive anti-neutrophil cytoplasmic antibody (ANCA).
METHODS: A retrospective analysis was performed for the children who were diagnosed with LN in the First Affiliated Hospital of Sun Yat-sen University from January 2003 to December 2019. According to the results of serum ANCA, they were divided into two groups: ANCA-positive group (n=59) and ANCAnegative group (n=454). The two groups were compared in terms of clinical manifestations, histopathological features, remission rate, and prognosis.
RESULTS: Compared with the ANCA-negative group, the ANCA-positive group had a significant reduction in leukocytes and a significant increase in erythrocyte sedimentation rate (P < 0.05). There were no significant differences between the two groups in serum creatinine, urine protein, and urine red blood cell count (P > 0.05). A total of 308 children underwent kidney biopsy. The results on light microscopy showed that compared with the ANCAnegative group, the ANCA-positive group had a significantly higher proportion of children with cellular fibrous crescents (P < 0.05) and a significantly lower proportion of children with immune complex deposition (P < 0.05). There were no significant differences between the two groups in the remission rate and survival rate (P > 0.05).
CONCLUSIONS: Children with ANCA-positive LN tend to have more severe renal pathological injury, which is not exactly parallel with clinical manifestations, suggesting that timely renal biopsy is of great importance.

Entities:  

Year:  2021        PMID: 33476538      PMCID: PMC7818163     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  18 in total

1.  SLE and rapidly progressive glomerulonephritis.

Authors:  Naveed N Masani; Louis J Imbriano; Vivette D D'Agati; Glen S Markowitz
Journal:  Am J Kidney Dis       Date:  2005-05       Impact factor: 8.860

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 3.  Advances in the care of children with lupus nephritis.

Authors:  Scott E Wenderfer; Natasha M Ruth; Hermine I Brunner
Journal:  Pediatr Res       Date:  2016-11-17       Impact factor: 3.756

4.  [Evidence-based guideline on diagnosis and treatment of lupus nephritis (2016)].

Authors: 
Journal:  Zhonghua Er Ke Za Zhi       Date:  2018-02-02

Review 5.  Paediatric-onset systemic lupus erythematosus.

Authors:  Clara Malattia; Alberto Martini
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-06       Impact factor: 4.098

6.  The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Authors:  Jan J Weening; Vivette D D'Agati; Melvin M Schwartz; Surya V Seshan; Charles E Alpers; Gerald B Appel; James E Balow; Jan A Bruijn; Terence Cook; Franco Ferrario; Agnes B Fogo; Ellen M Ginzler; Lee Hebert; Gary Hill; Prue Hill; J Charles Jennette; Norella C Kong; Philippe Lesavre; Michael Lockshin; Lai-Meng Looi; Hirofumi Makino; Luiz A Moura; Michio Nagata
Journal:  J Am Soc Nephrol       Date:  2004-02       Impact factor: 10.121

7.  Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.

Authors:  Hermine I Brunner; Dafna D Gladman; Dominique Ibañez; Murray D Urowitz; Earl D Silverman
Journal:  Arthritis Rheum       Date:  2008-02

Review 8.  Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.

Authors:  Marc Hilhorst; Pieter van Paassen; Jan Willem Cohen Tervaert
Journal:  J Am Soc Nephrol       Date:  2015-05-08       Impact factor: 10.121

9.  2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.

Authors:  George Bertsias; David Jayne; Dimitrios T Boumpas; Antonis Fanouriakis; Myrto Kostopoulou; Kim Cheema; Hans-Joachim Anders; Martin Aringer; Ingeborg Bajema; John Boletis; Eleni Frangou; Frederic A Houssiau; Jane Hollis; Adexandre Karras; Francesca Marchiori; Stephen D Marks; Gabriella Moroni; Marta Mosca; Ioannis Parodis; Manuel Praga; Matthias Schneider; Josef S Smolen; Vladimir Tesar; Maria Trachana; Ronald F van Vollenhoven; Alexandre E Voskuyl; Y K Onno Teng; Bernadette van Leew
Journal:  Ann Rheum Dis       Date:  2020-03-27       Impact factor: 19.103

10.  Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody.

Authors:  Shuai Wang; Jin Shang; Jing Xiao; Zhanzheng Zhao
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.